1 Juul KV, Schroeder M, Rittig S, Nørgaard JP. National Surveillance of Central Diabetes Insipidus (CDI) in Denmark: results from 5 years registration of 9309 prescriptions of desmopressin to 1285 CDI patients. J Clin Endocrinol Metab 2014; 99: 2181–87.
2 Turcu AF, Erickson BJ, Lin E, et al. Pituitary stalk lesions: the Mayo Clinic experience. J Clin Endocrinol Metab 2013; 98: 1812–18.
3 Brouwers M, Kho ME, Browman GP, et al, for the AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting and evaluation in healthcare. Can Med Assoc J 2010; 182: e839–42.
4 Schardt C, Adams MB, Owens T, Keitz S, Fontelo P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak 2007; 7: 16.
5 BMJ Best Practice. Evidence at the point of care. http://clinicalevidence.bmj.com/x/set/static/ebm/learn/665072. html (accessed June 7, 2021).
6 Werny D, Elfers C, Perez FA, Pihoker C, Roth CL. Pediatric central diabetes insipidus: brain malformations are common and few patients have idiopathic disease. J Clin Endocrinol Metab 2015; 100: 3074–80.
7 Richards GE, Thomsett MJ, Boston BA, DiMeglio LA, Shulman DI, Draznin M. Natural history of idiopathic diabetes insipidus. J Pediatr 2011; 159: 566–70.
8 Di Iorgi N, Allegri AE, Napoli F, et al. Central diabetes insipidus in children and young adults: etiological diagnosis and long-term outcome of idiopathic cases. J Clin Endocrinol Metab 2014; 99: 1264–72.
9 Maghnie M, Cosi G, Genovese E, et al. Central diabetes insipidus in children and young adults. N Engl J Med 2000; 343: 998–1007.
10 Cerbone MEA, Losa L, Moreno C, Spoudeas HA. Neuroimaging and eventual etiology of children with idiopathic thickened pituitary stalk (ITPS) and/or idiopathic central diabetes insipidus (ICDI): a single center experience on 53 children presenting over 30 years. Neuro-oncol 2016; 18 (suppl 3): iii165.
11 Santiprabhob J, Likitmaskul S, Boonyasiri A, Boonsathorn S, Buddawong T. Etiologies of central diabetes insipidus in Thai children. J Pediatr Endocrinol Metab 2005; 18: 653–61.
12 Liu SY, Tung YC, Lee CT, et al. Clinical characteristics of central diabetes insipidus in Taiwanese children. J Formos Med Assoc 2013; 112: 616–20.
13 Bajpai A, Kabra M, Menon PSN. Central diabetes insipidus: clinical profile and factors indicating organic etiology in children. Indian Pediatr 2008; 45: 463–68.
14 Catli G, Abaci A, Demir K, et al. Clinical profile and etiologies of children with central diabetes insipidus: a single-center experience from Turkey. J Pediatr Endocrinol Metab 2012; 25: 499–502.
15 Jaruratanasirikul S, Janjindamai S, Sriplung H, Patarakijvanich N, Vasiknanonte P. Etiologies of central diabetes insipidus in children: 15 years experience in Songklanagarind hospital, Thailand. J Med Assoc Thai 2002; 85: 765–71.
16 Hamilton BE, Salzman KL, Osborn AG. Anatomic and pathologic spectrum of pituitary infundibulum lesions. AJR Am J Roentgenol 2007; 188: 223–32.
17 Schneider P, Evaniew N, Rendon JS, et al. Moving forward through consensus: protocol for a modified Delphi approach to determine the top research priorities in the field of orthopaedic oncology. BMJ Open 2016; 6: e011780.
18 Di Iorgi N, Morana G, Maghnie M. Pituitary stalk thickening on MRI: when is the best time to re-scan and how long should we continue re-scanning for? Clin Endocrinol (Oxf) 2015; 83: 449–55.
19 Robison NJ, Prabhu SP, Sun P, et al. Predictors of neoplastic disease in children with isolated pituitary stalk thickening. Pediatr Blood Cancer 2013; 60: 1630–35.
20 Leger J, Velasquez A, Garel C, Hassan M, Czernichow P. Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus. J Clin Endocrinol Metab 1999; 84: 1954–60.
21 Freund KMN, Dastamani A, Dorward N, et al. A 7-year update report of a national, interdisciplinary endeavour to improve outcomes for children and young people under 19 years of age with hypothalamic pituitary axis tumours (HPAT) using multi-site video conferencing. Horm Res Paediatr 2018; 82: 496–97.
22 Peyster RG, Hoover ED, Adler LP. CT of the normal pituitary stalk. AJNR Am J Neuroradiol 1984; 5: 45–47.
23 Tien RD, Newton TH, McDermott MW, Dillon WP, Kucharczyk J. Thickened pituitary stalk on MR images in patients with diabetes insipidus and Langerhans cell histiocytosis. AJNR Am J Neuroradiol 1990; 11: 703–08.
24 Simmons GE, Suchnicki JE, Rak KM, Damiano TR. MR imaging of the pituitary stalk: size, shape, and enhancement pattern. AJR Am J Roentgenol 1992; 159: 375–77.
25 Satogami N, Miki Y, Koyama T, Kataoka M, Togashi K. Normal pituitary stalk: high-resolution MR imaging at 3T. AJNR Am J Neuroradiol 2010; 31: 355–59.
26 Godano E, Morana G, Di Iorgi N, et al. Role of MRI T2-DRIVE in the assessment of pituitary stalk abnormalities without gadolinium in pituitary diseases. Eur J Endocrinol 2018; 178: 613–22.
27 Bianco D, Napoli F, Morana G, et al. Endocrine outcomes in central diabetes insipidus: the predictive value of neuroimaging “mismatch pattern”. J Clin Endocrinol Metab 2020; 105: 3562–74.
28 Sbardella E, Joseph RN, Jafar-Mohammadi B, Isidori AM, Cudlip S, Grossman AB. Pituitary stalk thickening: the role of an innovative MRI imaging analysis which may assist in determining clinical management. Eur J Endocrinol 2016; 175: 255–63.
29 Ranadive SA, Ersoy B, Favre H, et al. Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus. Clin Endocrinol (Oxf) 2009; 71: 388–93.
30 Klyn V, Dekeyzer S, Van Eetvelde R, et al. Presence of the posterior pituitary bright spot sign on MRI in the general population: a comparison between 1.5 and 3T MRI and between 2D-T1 spin-echo- and 3D-T1 gradient-echo sequences. Pituitary 2018; 21: 379–83.
31 Cerbone M, Güemes M, Wade A, Improda N, Dattani M. Endocrine morbidity in midline brain defects: differences between septo-optic dysplasia and related disorders. EClinicalMedicine 2020; 19: 100224.
32 Makras P, Samara C, Antoniou M, et al. Evolving radiological features of hypothalamo-pituitary lesions in adult patients with Langerhans cell histiocytosis (LCH). Neuroradiology 2006; 48: 37–44.
33 Caranci F, Leone G, Ponsiglione A, et al. Imaging findings in hypophysitis: a review. Radiol Med (Torino) 2020; 125: 319–28.
34 Pal R, Rai A, Vaiphei K, et al. Intracranial germinoma masquerading as secondary granulomatous hypophysitis: a case report and review of literature. Neuroendocrinology 2020; 110: 422–29.
35 Maghnie M. Diabetes insipidus. Horm Res 2003; 59 (suppl 1): 42–54.
36 Sethi RV, Marino R, Niemierko A, Tarbell NJ, Yock TI, MacDonald SM. Delayed diagnosis in children with intracranial germ cell tumors. J Pediatr 2013; 163: 1448–53.
37 Zhang H, Zhang P, Fan J, et al. Determining an optimal cutoff of serum β-human chorionic gonadotropin for assisting the diagnosis of intracranial germinomas. PLoS One 2016; 11: e0147023.
38 Hu M, Guan H, Lau CC, et al. An update on the clinical diagnostic value of β-hCG and αFP for intracranial germ cell tumors. Eur J Med Res 2016; 21: 10.
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.